Actinium Pharmaceuticals announces enrollment in imaging trial to guide ATNM-400 development in solid tumors beyond prostate cancer

Actinium Pharmaceuticals announced enrollment in an imaging trial to guide ATNM-400 development in solid tumors beyond prostate cancer.

Detected & updated continuously · Source: Nebula